View Item 

Show simple item record

Bayesian methods to compare dose levels with placebo in a small n, sequential, multiple assignment, randomized trial
dc.contributor.authorFang, Fang
dc.contributor.authorHochstedler, Kimberly A.
dc.contributor.authorTamura, Roy N.
dc.contributor.authorBraun, Thomas M.
dc.contributor.authorKidwell, Kelley M.
dc.date.accessioned2021-02-04T21:53:16Z
dc.date.available2022-03-04 16:53:15en
dc.date.available2021-02-04T21:53:16Z
dc.date.issued2021-02-20
dc.identifier.citationFang, Fang; Hochstedler, Kimberly A.; Tamura, Roy N.; Braun, Thomas M.; Kidwell, Kelley M. (2021). "Bayesian methods to compare dose levels with placebo in a small n, sequential, multiple assignment, randomized trial." Statistics in Medicine 40(4): 963-977.
dc.identifier.issn0277-6715
dc.identifier.issn1097-0258
dc.identifier.urihttps://hdl.handle.net/2027.42/166252
dc.publisherWiley Periodicals, Inc.
dc.subject.otheradaptive randomization
dc.subject.otherrepeated measures
dc.subject.otherclinical trial
dc.titleBayesian methods to compare dose levels with placebo in a small n, sequential, multiple assignment, randomized trial
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbsecondlevelStatistics and Numeric Data
dc.subject.hlbtoplevelHealth Sciences
dc.subject.hlbtoplevelScience
dc.subject.hlbtoplevelSocial Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/166252/1/sim8813.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/166252/2/sim8813_am.pdf
dc.identifier.doi10.1002/sim.8813
dc.identifier.doihttps://dx.doi.org/10.7302/175
dc.identifier.sourceStatistics in Medicine
dc.identifier.citedreferenceFDA guidance for industry (Draft). Rare diseases: common issues in drug development; 2015.
dc.identifier.citedreferenceWilliamson T, Eliasziw M, Fick GH. Log‐binomial models: exploring failed convergence. Emerg Themes Epidemiol. 2013; 10 ( 1 ): 14.
dc.identifier.citedreferenceWei B, Braun TM, Tamura RN, Kidwell KM. A Bayesian analysis of small n sequential multiple assignment randomized trials (snSMARTs). Stat Medic. 2018; 37 ( 26 ): 3723 ‐ 3732.
dc.identifier.citedreferenceHonkanen VEA, Siegel AF, Szalai JP, Berger V, Feldman BM, Siegel JN. A three‐stage clinical trial design for rare disorders. Stat Medic. 2001; 20 ( 20 ): 3009 ‐ 3021.
dc.identifier.citedreferenceGriggs RC, Batshaw M, Dunkle M, et al. Clinical research for rare disease: opportunities, challenges and solutions. Mol Genet Metab. 2009; 96 ( 1 ): 20 ‐ 26.
dc.identifier.citedreferenceLevin KA. Study design VII. Randomised controlled trials. Evidence‐Based Dentistry. 2007; 8 ( 1 ): 22.
dc.identifier.citedreferenceNason M, Follmann D. Design and analysis of crossover trials for absorbing binary endpoints. Biometrics. 2010; 66 ( 3 ): 958 ‐ 965.
dc.identifier.citedreferenceMakubate B, Senn S. Planning and analysis of cross‐over trials in infertility. Stat Medic. 2010; 29 ( 30 ): 3203 ‐ 3210.
dc.identifier.citedreferenceAlmirall D, Compton SN, Rynn MA, Walkup JT, Murphy SA. SMARTer discontinuation trial designs for developing an adaptive treatment strategy. J Child Adolescent Psychopharmacol. 2012; 22 ( 5 ): 364 ‐ 374.
dc.identifier.citedreferenceRosner GL, Stadler W, Ratain MJ. Randomized discontinuation design: application to cytostatic antineoplastic agents. J Clin Oncol. 2002; 20 ( 22 ): 4478 ‐ 4484.
dc.identifier.citedreferenceMurphy SA. Optimal dynamic treatment regimes. J Royal Stat Soc Ser B (Stat Methodol). 2003; 65 ( 2 ): 331 ‐ 355.
dc.identifier.citedreferenceRobins J. A new approach to causal inference in mortality studies with a sustained exposure period–application to control of the healthy worker survivor effect. Math Modell. 1986; 7 ( 9‐12 ): 1393 ‐ 1512.
dc.identifier.citedreferenceMurphy SA. An experimental design for the development of adaptive treatment strategies. Stat Medic. 2005; 24 ( 10 ): 1455 ‐ 1481.
dc.identifier.citedreferenceLavori PW, Dawson R. A design for testing clinical strategies: biased adaptive within‐subject randomization. J Royal Stat Soc Ser A (Stat Soc). 2000; 163 ( 1 ): 29 ‐ 38.
dc.identifier.citedreferenceTamura RN, Krischer JP, Pagnoux C, et al. A small n sequential multiple assignment randomized trial design for use in rare disease research. Contemp Clin Trials. 2016; 46: 48 ‐ 51.
dc.identifier.citedreferenceGupta S, Faughnan ME, Tomlinson GA, Bayoumi AM. A framework for applying unfamiliar trial designs in studies of rare diseases. J Clin Epidemiol. 2011; 64 ( 10 ): 1085 ‐ 1094.
dc.identifier.citedreference107th Congress rare diseases act of 2002. Pub Law; 2002:107‐280.
dc.working.doi10.7302/175en
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
sim8813.pdf
Size:
719.7KB
Format:
PDF
View/Open
Name:
sim8813_am.pdf
Size:
1.116MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.